I moved to Oxford in 2017 as an NIHR Clinician Scientist to research optimal therapeutic strategies for patients with psoriatic arthritis (PsA). I am establishing a new psoriatic arthritis service in Oxford to see if a more practical version of ‘treat to target’ approach can be run successfully in a routine NHS Clinic. We have previously shown in the TICOPA trial that this ‘Treat to Target’ approach (where patients’ treatment is increased regularly until a target was achieved) improves patients’ outcomes. I am also testing different treatment choices within this to try to personalise care to the individual patient. We will see if patients with mild disease can be treated successfully without being put onto more powerful arthritis drugs, avoiding the side effects of these and to see if patients with severe disease do better if they start on stronger arthritis drugs.